Advances in regenerative medicine manufacturing continue to be a priority for achieving the
full commercial potential of important breakthrough therapies. Equally important will be the …

Regenerative medicine is poised to become a significant industry within the medical field. As
such, the development of strategies and technologies for standardized and automated …

Manufacturing Challenges in Regenerative Medicine | Science Translational Medicine news
careers commentary Journals Science Science brought to you byGoogle Indexer Log in science …

The cell therapy industry is rapidly growing with several new products approved for clinical
use over the past few years and many more currently in clinical trials. Nonetheless, a …

The pharmaceutical, biotechnology and life sciences industry was worth approximately US
$1 trillion in 2010, of which 73.2% was attributed to pharmaceuticals, 25% to biotechnology …

This chapter will cover the challenges and opportunities in regenerative medicine
manufacturing. We will start with a brief background on the importance of advancing …

Although cell therapies continue to reshape multiple therapeutics areas, the field is still
grappling with how to best manufacture therapies. Allogeneic therapies are currently …

Abstract Summary The Regenerative Medicine Foundation Annual Conference held on May
6 and 7, 2014, had a vision of assisting with translating tissue engineering and regenerative …

Decentralized or “redistributed” manufacturing has the potential to revolutionize the
manufacturing approach for cell and gene therapies (CGTs), moving away from the “Fordist” …

Background: A novel manufacturing industry is emerging to translate unique cellular therapy
bioprocesses to robust, scaled manufacturing production for successful clinical translation …